Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D W Bowles

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Journal of Insect Physiology|February 13, 2001
Characterization of Rb uptake into Sf9 cells using cation chromatography: evidence for a K-Cl cotransporterD W. Bowles, C M Gillen
Drugs of Today (Barcelona, Spain : 1998)|October 3, 2013
Afatinib for the treatment of patients with EGFR-positive non-small cell lung cancerD W Bowles, A Weickhardt, A Jimeno
Drugs of Today (Barcelona, Spain : 1998)|December 8, 2011
Multi-targeted tyrosine kinase inhibitors in clinical development: focus on XL-184 (cabozantinib)D W Bowles, E R Kessler, A Jimeno
Drugs of Today (Barcelona, Spain : 1998)|October 4, 2012
New and established tyrosine kinase inhibitors for chronic myeloid leukemiaC D Thienelt, K Green, D W Bowles
Drugs of Today (Barcelona, Spain : 1998)|October 11, 2018
Update on multikinase inhibitor therapy for differentiated thyroid cancerV R Agrawal, G Jodon, R Mushtaq, et al.
Drugs of Today (Barcelona, Spain : 1998)|December 13, 2018
New therapies for anaplastic thyroid cancerV R Agrawal, J Hreno, T Patil, et al.
Drugs of Today (Barcelona, Spain : 1998)|July 31, 2012
Vismodegib in basal cell carcinomaR N Amaria, D W Bowles, K D Lewis, et al.
Drugs of Today (Barcelona, Spain : 1998)|October 31, 2012
Axitinib, a new therapeutic option in renal cell carcinomaE R Kessler, D W Bowles, T W Flaig, et al.
Drugs of Today (Barcelona, Spain : 1998)|April 27, 2012
Crizotinib for the treatment of patients with advanced non-small cell lung cancerD W Bowles, A J Weickhardt, R C Doebele, et al.
Drugs of Today (Barcelona, Spain : 1998)|June 27, 2017
Cabozantinib use in renal cell carcinomaA J Neuwelt, S Mathur, A T Johnson, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Journal of Insect Physiology|February 13, 2001
Characterization of Rb uptake into Sf9 cells using cation chromatography: evidence for a K-Cl cotransporterD W. Bowles, C M Gillen
Drugs of Today (Barcelona, Spain : 1998)|October 3, 2013
Afatinib for the treatment of patients with EGFR-positive non-small cell lung cancerD W Bowles, A Weickhardt, A Jimeno
Drugs of Today (Barcelona, Spain : 1998)|December 8, 2011
Multi-targeted tyrosine kinase inhibitors in clinical development: focus on XL-184 (cabozantinib)D W Bowles, E R Kessler, A Jimeno
Drugs of Today (Barcelona, Spain : 1998)|October 4, 2012
New and established tyrosine kinase inhibitors for chronic myeloid leukemiaC D Thienelt, K Green, D W Bowles
Drugs of Today (Barcelona, Spain : 1998)|October 11, 2018
Update on multikinase inhibitor therapy for differentiated thyroid cancerV R Agrawal, G Jodon, R Mushtaq, et al.
Drugs of Today (Barcelona, Spain : 1998)|December 13, 2018
New therapies for anaplastic thyroid cancerV R Agrawal, J Hreno, T Patil, et al.
Drugs of Today (Barcelona, Spain : 1998)|July 31, 2012
Vismodegib in basal cell carcinomaR N Amaria, D W Bowles, K D Lewis, et al.
Drugs of Today (Barcelona, Spain : 1998)|October 31, 2012
Axitinib, a new therapeutic option in renal cell carcinomaE R Kessler, D W Bowles, T W Flaig, et al.
Drugs of Today (Barcelona, Spain : 1998)|April 27, 2012
Crizotinib for the treatment of patients with advanced non-small cell lung cancerD W Bowles, A J Weickhardt, R C Doebele, et al.
Drugs of Today (Barcelona, Spain : 1998)|June 27, 2017
Cabozantinib use in renal cell carcinomaA J Neuwelt, S Mathur, A T Johnson, et al.
Pageof 2